<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39387429</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2791-6421</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>The Turkish journal of pediatrics</Title><ISOAbbreviation>Turk J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Common viral respiratory infections in children with cancer during the COVID-19 pandemic: a multicenter study from Türkiye.</ArticleTitle><Pagination><StartPage>401</StartPage><EndPage>411</EndPage><MedlinePgn>401-411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24953/turkjpediatr.2024.4536</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Microbiologic confirmation of respiratory tract infections gained importance during the coronavirus disease 2019 (COVID-19) pandemic. This study retrospectively evaluated seasonal distribution, clinical presentation, and complications of respiratory viral infections (RVIs) other than COVID-19 in children with cancer during and after the pandemic lockdown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred and sixty-five inpatient and outpatient RVI episodes in 219 pediatric cancer patients confirmed by multiplex reverse transcriptase polymerase chain reaction (RT-PCR) panels from 13 centers were enrolled.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-six (32.5%) of the total 265 episodes occurred in 16 months corresponding to the lockdowns in Türkiye, and the remaining 67.5% in 10 months thereafter. Human rhinovirus/enterovirus (hRE) (48.3%) was the most common agent detected during and after lockdown. Parainfluenza virus (PIV) (23.0%), influenza virus (9.8%), and respiratory syncytial virus (RSV) (9.1%) were the other common agents. The 28.7% of episodes were lower respiratory tract infections (LRTIs), and complications and mortality were higher than upper respiratory tract infections (URTIs) (25.0% vs 5.3%). Bacteremia was identified in 11.5% of culture-drawn episodes. Treatment delay in one-third and death within four weeks after RVI in 4.9% of episodes were observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">During the pandemic, fewer episodes of RVIs occurred during the lockdown period. Respiratory viruses may cause complications, delays in treatment, and even death in children with cancer. Therefore, increased awareness of RVIs and rapid detection of respiratory viruses will benefit the prevention and, in some cases, abrupt supportive and some antiviral treatment of RVI in children with cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaçar</LastName><ForeName>Dilek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kebudi</LastName><ForeName>Rejin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology-Oncology, Oncology Institute, İstanbul University, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özyörük</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuğcu</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology-Oncology, İstanbul University İstanbul Medical Faculty, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahadır</LastName><ForeName>Ayşenur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Zeynep Canan</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özgüven</LastName><ForeName>Ali Aykan</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Celal Bayar University Faculty of Medicine, Manisa, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhan</LastName><ForeName>Mehmet Fatih</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Sakarya University Faculty of Medicine, Sakarya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Türedi Yıldırım</LastName><ForeName>Ayşen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Celal Bayar University Faculty of Medicine, Manisa, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albayrak</LastName><ForeName>Canan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kartal</LastName><ForeName>İbrahim</ForeName><Initials>İ</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarı</LastName><ForeName>Neriman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokgöz</LastName><ForeName>Hüseyin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albayrak</LastName><ForeName>Meryem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Kırıkkale University Faculty of Medicine, Kırıkkale, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canbolat Ayhan</LastName><ForeName>Aylin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, İstanbul Medeniyet University Faculty of Medicine, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eroğlu</LastName><ForeName>Nilgün</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Ankara Etlik City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydın</LastName><ForeName>Sultan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Antalya Education and Research Hospital, Antalya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Üzel</LastName><ForeName>Veysiye Hülya</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Dicle University Faculty of Medicine, Diyarbakır, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zülfikar</LastName><ForeName>Bülent</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology-Oncology, Oncology Institute, İstanbul University, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yıldırım</LastName><ForeName>Ülkü Miray</ForeName><Initials>ÜM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology-Oncology, Oncology Institute, İstanbul University, İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Büyükavcı</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gülen</LastName><ForeName>Hüseyin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Celal Bayar University Faculty of Medicine, Manisa, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Töret</LastName><ForeName>Ersin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bör</LastName><ForeName>Özcan</ForeName><Initials>Ö</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özbek</LastName><ForeName>Namık Yaşar</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ergürhan İlhan</LastName><ForeName>İnci</ForeName><Initials>İ</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, University of Health Sciences Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaralı</LastName><ForeName>Neşe</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology Oncology, Yıldırım Beyazıt University Faculty of Medicine, Ankara Bilkent City Hospital, Ankara, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turk J Pediatr</MedlineTA><NlmUniqueID>0417505</NlmUniqueID><ISSNLinking>0041-4301</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">respiratory viral infections</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>21</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>21</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39387429</ArticleId><ArticleId IdType="doi">10.24953/turkjpediatr.2024.4536</ArticleId><ArticleId IdType="pii">4536</ArticleId></ArticleIdList></PubmedData></PubmedArticle>